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Abstract:  
Research question: Is prepregnancy maternal underweight associated with perinatal 
outcomes of singletons who were conceived by assisted reproductive technology 
(ART)? 
Design: A 10-year (2006-2015) Chinese sample of 6538 women and their singletons 
who were conceived by ART was used to examine the association between 
prepregnancy maternal underweight and perinatal outcomes. Propensity scores(PS) 
for underweight were calculated for each participant using multivariable logistic 
regression, which was used to match 740 (91.35% of 810) underweight women with 
740 normal weight women and then the effects of underweight on birth weight (BW) 
and gestational age (GA) were assessed by the generalized estimating equation (GEE) 
model. 
Results: After PS matching, the BW was lower (difference=-136.83 g, 95% 
CI=-184.11 to -89.55 g) in the underweight group than in the normal weight group. 
The risks of low birth weight (LBW) and small for gestational age (SGA) were 
increased in the underweight group compared with those in the normal weight group 
(LBW: RR=1.64, 95% CI=1.01 to 2.67; SGA: RR=1.46, 95% CI=1.06 to 2.02). The 
risks of fetal macrosomia and being large for gestational age (LGA) were decreased in 
the underweight group compared with those in the normal weight group (macrosomia: 
RR=0.39, 95% CI=0.26 to 0.61; LGA: RR=0.36, 95% CI=0.24 to 0.53). The 
associations between underweight and GA and preterm birth (PTB) were not 
statistically significant. 
Conclusions: Among women undergoing ART, prepregnancy maternal underweight 
was associated with lower BW, increased LBW and SGA risks and decreased fetal 
macrosomia and LGA risks in singletons. 
 
Key words: underweight; assisted reproductive technology; preterm birth; low birth 
weight; propensity score matching  
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Introduction 
In the past 40 years, assisted reproductive technology (ART), such as in vitro 
fertilization (IVF) and intracytoplasmic sperm injection (ICSI), has become a 
widespread option for the treatment of infertile couples around the world. It is 
estimated that ART has contributed to the birth of over 5 million live-born babies 
worldwide, and the proportion of infants who are born in China as a result of ART is 
greater than 1% (Adamson et al., 2018; Yang et al., 2014). Although ART helps 
millions of infertile couples to achieve pregnancy, ART is associated with potential 
health risks for both mothers and infants. Previous research has shown that infants 
who are conceived by ART have an increased risk of adverse pregnancy outcomes, 
such as low birth weight (LBW), preterm birth (PTB) and congenital malformations 
compared with those who are conceived spontaneously (McDonald et al., 2009; 
Cavoretto et al., 2018; Dunietz et al., 2015; Jancar et al., 2018; Zheng et al., 2018). 
The nutritional status of a woman before and during pregnancy is important for a 
healthy pregnancy outcome (Gondwe et al., 2018). Maternal underweight in early 
pregnancy, which is common in China and even in Asia, is a leading risk factor for 
adverse birth outcomes, including LBW, PTB, small for gestational age (SGA), and 
stillbirth (Siega-Riz et al., 1993; Abrams et al., 1995; Li et al., 2015). Liu 
systematically reviewed and collected 60 studies, of which 1,392,799 women were 
included and the proportion of underweight pregnant women was 8.18%, and found 
that mothers who were underweight had a higher risk of PTB (OR=1.30, 95% CI=1.13 
to 1.49), and delivering an infant that was SGA (OR=1.67, 95% CI=1.49 to 1.87) and 
LBW (OR=1.67, 95% CI=1.39 to 2.02) (Liu et al., 2016). However, the studies of the 
relationship between maternal underweight before pregnancy and fetal growth with 
ART treatment are limited (Cai et al., 2017; Singh et al., 2012). The goal of our study 
was to reveal the impact of prepregnancy maternal underweight on birth weight (BW) 
and gestational age (GA) among infants who were conceived by ART. We collected 10 
years of data, including ART treatments and the perinatal outcomes to compare the 
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BW and GA between the underweight group and normal weight group in a single ART 
center in Northwest China. 
Methods 
Study design and population 
This was a retrospective cohort study of all women who had a singleton birth 
resulting from an embryo transfer between January 2006 and March 2015 at the 
Assisted Reproduction Center of Northwest Women’s and Children’s Hospital, Xi’an, 
Northwestern China. Data were extracted from the clinical records. In this time frame, 
a total of 12,572 infants were born with IVF/ICSI treatment. We excluded 3,577 
multiple births, 1,965 mothers with BMI ≥ 24 kg/m2, 143 mothers with missing BMI 
and 349 mothers with missing covariates in singleton pregnancy, leaving a total 6,538 
ART mothers with their singleton infants in this study. Of these, 810 mothers were 
underweight and 5,728 were normal weight (Fig. 1). 
In the Shaanxi province of China, it is a requirement that all ART birth outcomes, 
including BW and GA, are reported to the Shaanxi Assisted Reproduction Database. 
Demographic data that were collected from the Assisted Reproduction Center of 
Northwest Women’s and Children’s Hospital included year of transfer, maternal age, 
BMI, gravidity, parity, smoking history, etiology of infertility, sperm donation, 
controlled ovarian hyperstimulation protocol, fertilization method, assisted hatching, 
basal serum follicle stimulating hormone (FSH) level, antral follicle count, 
endometrial thickness, fresh/frozen-thaw embryo transfer, blastocyst/cleavage-stage 
transfer, number of embryos transferred, number of gestational sacs by 
ultrasonographic visualization and infant’s sex as assessed and collected by the 
patient’s treating clinician.  
BMI assessment 
Nurses measured and recorded the weight and height of all women after the 
initial consultation. The BMI was calculated as kg/m
2
. All 6,538 women were 
separated into two groups based on the classification and evaluation criteria of weight 
for Chinese adults (National Health and Family Planning Commission of the People’s 
Republic of China, 2011) as follows: underweight group (low BMI group): BMI <18.5 
kg/m
2
; normal weight group (normal BMI group): 18.5 kg/m
2
 ≤ BMI <24.00 kg/m2. 
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The definitions of perinatal outcomes  
The primary outcomes were BW and GA. LBW is defined as BW <2500 g; fetal 
macrosomia is defined as BW ≥ 4000 g; The sex- and gestational age-adjusted birth 
weight Z score and birth weight centile was calculated according to international 
standards developed by the International Fetal and Newborn Growth Consortium for 
the 21st Century (Villar et al., 2014). GA was calculated by the number of days from 
the day of transfer to birth plus the age of the embryo and plus 14 days according the 
formula suggested by American College of Obstetricians and Gynecologists (ACOG) 
(ACOG, 2017). Full term is defined as 37- 42 complete weeks of GA; PTB is defined 
as born before 37 weeks of GA; SGA is defined as a BW below the 10th percentile for 
the gestational age; large for gestational age (LGA) is defined as a BW above the 90th 
percentile for that gestational age; appropriate for gestational age (AGA) is defined as 
a BW between the 10th and 90th percentile for that GA. 
Confounding variables 
Potential correlated factors of perinatal outcomes such as patient baseline 
demographical characteristics, clinical characteristics, and treatment procedure were 
also collected for the study subjects, including: year of transfer, maternal age, 
gravidity, parity, maternal smoking history, etiology of infertility, sperm donation, 
controlled ovarian hyperstimulation protocol, fertilization method, assisted hatching, 
basal serum FSH, antral follicle count, endometrial thickness, frozen or fresh embryo 
transfer, cleavage stage or blastocyst transfer, no. of embryos transferred, no. of 
gestational sacs by ultrasonographic visualization and infant’s sex. 
Ethical approval 
The Human Research Ethics Committee of the Northwest Women’s and 
Children’s Hospital approved this study. The ethics committee that approved this 
study waived the need to obtain informed consent. All of the research was performed 
in accordance with the relevant guidelines and regulations. 
Statistical analysis 
We categorized 6,538 participants into the underweight group and normal weight 
group. Of the 6,538 participants, 810 (12.39% of 6,538) participants were 
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underweight. Next, we estimated the propensity score (PS) of each participant using a 
multivariable logistic regression model, in which the BMI group was modeled using 
all of the baseline participant characteristics in Table 1. Then, we used the nearest 
neighbor within caliper to match each participant in the underweight with one in the 
normal weight group, thus matching 740 (12.92% of 5,728) participants with low BMI 
to 740 participants with normal BMI with similar estimated PS (Ahmed et al., 2006). 
In our matching algorithm, we matched each participant in the underweight group 
with a participant in the normal weight group who had a PS that was similar to five 
decimal places. The nearest neighbor within caliper matching function is as follows: 
                 C(𝑃𝑖) =  min𝑗 ||𝑃𝑖 − 𝑃𝑗|| , 𝑗 ∈ 𝐼0 
                     ||𝑃𝑖 − 𝑃𝑗|| < 𝜀 , 𝑗 ∈ 𝐼0 
Pi : PS of the underweight group; Pj : PS of the normal weight group; I0: the set of 
normal weight group; C(Pi): the matching normal weight participant for the 
underweight participant; ε: tolerance for matching (caliper). 
The prematch mean PS for each underweight and normal weight participant was 
0.139607 and 0.121428, respectively (absolute standardized difference=55.41%; t-test 
P <0.001). After matching, the mean PS for the underweight and normal weight 
participants were 0.132429 and 0.132435, respectively (absolute standardized 
difference=0.02%; t-test P=0.998). Pearson chi-square and Student’s test were used to 
compare the baseline characteristics of the underweight versus normal weight 
participants before and after matching. Wilcoxon rank test and Fisher exact test were 
used if the assumptions for Student’s test and Pearson chi-square were violated. For a 
continuous covariate, the absolute standardized difference is defined as: 
d =
(?̅?𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 − ?̅?𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
√𝑠𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
2 + 𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙
2
2
 
where ?̅?𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡  and ?̅?𝑐𝑜𝑛𝑡𝑟𝑜𝑙  denote the sample mean of the covariate in 
underweight and normal weight subjects, respectively, whereas 𝑠𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
2  and 
𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙
2
 denote the sample variance of the covariates in underweight and normal 
weight subjects, respectively. For dichotomous variables, the standardized difference 
is defined as: 
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d =
(?̂?𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 − ?̂?𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
√?̂?𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡(1 − ?̂?𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡) + ?̂?𝑐𝑜𝑛𝑡𝑟𝑜𝑙(1 − ?̂?𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
2
 
where ?̂?𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 and ?̂?𝑐𝑜𝑛𝑡𝑟𝑜𝑙 denote the prevalence or mean of the dichotomous 
variable in underweight and normal weight subjects, respectively (Austin et al., 2011). 
We estimated the crude mean differences and 95% confidence intervals for BW 
and GA in a generalized estimating equation (GEE) model 1, with the BMI group as 
the only predictor, the matching number as the cluster effect, a normal distribution, 
and adjusted for the set of covariates in model 2. We also estimated the relative risks 
(RR) and 95% confidence intervals for LBW, PTB, SGA and LGA in model 1 and 
adjusted for the set of covariates in model 2 using GEE binomial regression models 
with log link. 
We conducted sensitivity analyses using two approaches to assess the robustness 
of our findings regarding the effects of underweight on birth outcomes to changes in 
the analytic approach. To address concerns about incomplete matching, we analysed 
data from all 6,538 participants, using generalized linear model adjustment for all 
baseline covariates, and subclassification based on tertiles of PS. To examine for the 
potential heterogeneity of a BMI effect on BW, GA and SGA, we estimated the effects 
of underweight in several subgroups, using the prematch cohort of 6,538 patients. We 
then estimated the effect of underweight in each of the subgroups using generalized 
linear model adjustment for all baseline covariates. All of the analyses were 
performed with STATA version 12.0 software (STATA Corporation, College Station, 
TX, USA). The level of significance was set at p<0.05. 
Results 
Participants’ characteristics 
The mean (±SD) age of the 1,480 PS-matched women was 28.90 (±3.58) years, 
925 (62.50%) embryos were transferred between 2013 to 2015 and 989 (66.82%) 
received IVF treatment. Table 1 compares the baseline characteristics of the 
participants by BMI before and after PS matching. Before matching, the underweight 
women were younger. They were more likely to have higher basal serum FSH level, 
sperm donation and male infertility. However, the underweight women were also 
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more likely to have less gravidity, parity and female infertility.   
After matching, underweight and normal weight women were similar with 
regards to all of the 19 baseline covariates (Table 1 and Fig. 2). Our PS matching 
reduced the standardized differences for all of the observed covariates to below 10% 
in absolute value except basal serum FSH level, demonstrating a substantial 
improvement in the covariate balance across the BMI groups (Fig. 2). 
Underweight and BW  
After PS matching, BW, BW Z score, and BW centiles were lower in the 
underweight group compared with that of the normal weight group (BW: mean 
difference= -136.83 g, 95% CI=-184.11 to -89.55 g, P<0.001; BW Z score: mean 
difference=-0.30, 95% CI=-0.39 to -0.20, P<0.001; BW centiles: mean 
difference=-8.41, 95% CI=-11.21 to -5.62, P<0.001) (Table 2). Higher risk of LBW 
(BW <2500 g) was observed in the underweight group compared with those of the 
normal weight group (LBW: RR=1.64, 95% CI=1.01 to 2.67, P=0.046). Lower risk of 
fetal macrosomia (BW ≥ 4000 g) was observed in the underweight group compared 
with the normal weight group (fetal macrosomia: RR=0.39, 95% CI=0.26 to 0.61, 
P<0.001). These associations remained essentially unchanged after adjustment for 
baseline covariates (Table 2).  
Underweight and GA  
After PS matching, there was no significant difference in GA between the 
underweight group and the normal weight group (difference=-0.02 week, 95% 
CI=-0.18 to 0.13 week, P=0.782) (Table 2). Compared with the normal weight group, 
the risk of PTB (<37 weeks) in the underweight group showed no significant increase 
(RR=1.02, 95% CI=0.69 to 1.50, P=0.916). Compared with the normal underweight 
group, the risks of GA between 37 weeks and 42 weeks, GA >40 weeks and GA >41 
weeks also showed no significant increases in the underweight group. These 
associations remained essentially unchanged after adjustment for baseline covariates 
(Table 2). 
Underweight and SGA, AGA and LGA  
After PS matching, higher risks of SGA and AGA were observed in the 
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underweight group compared with the normal weight group (SGA: RR=1.46, 95% 
CI=1.06 to 2.02, P=0.021; AGA: RR=1.05, 95% CI=1.00 to 1.10, P=0.040). In 
addition, a lower risk of LGA was observed in the underweight group compared with 
the normal weight group (RR=0.36, 95% CI=0.24 to 0.53, P<0.001). These 
associations remained essentially unchanged after adjustment for baseline covariates 
(Table 2). 
Sensitivity analyses 
In the full (prematched) cohort (n=6,538), compared with the mean (3292.45 g) 
BW of the normal weight group, the mean BW was 3177.64 g in the underweight 
group, and this association was significant when adjusted for all baseline covariates 
(adjusted difference=-114.28, 95% CI=-151.26 to -77.30 g, P<0.001). Compared with 
7.86% SGA in the normal weight group, 10.99% of infants were SGA in the 
underweight group, and this association was significant when adjusted for all baseline 
covariates (RR=1.43, 95% CI=1.15 to 1.78, P=0.001). Compared with the mean GA 
(39.03 weeks) in the normal weight group, the mean GA was 39.06 weeks in the 
underweight group, and this association was not significant when adjusted for all 
baseline covariates (adjusted difference=-0.01 week, 95% CI=-0.14 to 0.11 week, 
P=0.829).  
Among the participants in PS tertiles two and three (n=4,280), we observed similar 
associations between being underweight and BW, GA and SGA when all baseline 
covariates were adjusted (BW: adjusted difference=-115.59 g, 95% CI=-74.68 to 
-156.49 g, P<0.001; GA: adjusted difference=-0.10 week, 95% CI=-0.15 to 0.12 week, 
P=0.849; SGA: adjusted RR=1.52, 95% CI=1.20 to 1.93, P=0.001).  
Subgroup analyses 
The association of being underweight with perinatal outcomes was noted across a 
wide spectrum of participants (Table 3). Maternal underweight was associated with 
lower BW in all subgroups. Maternal underweight was not associated with lower GA 
in all subgroups. Maternal underweight was associated with a higher risk of SGA in all 
subgroups, and this association was statistically significant for ages between 28-30 
years, first pregnancy, ICSI treatment, FSH <0.74 U/L, fresh embryo transfer, 
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cleavage stage or blastocyst transfer, endometrial thickness <9.6 or >11.4 mm, no. of 
embryos transferred ≥ 2, and girl or boy infants. There were no significant 
interactions between BMI and any of the covariates. 
Discussion 
In a large cohort of pregnant women with ART treatment who received follow-up 
for their perinatal outcomes, we found that prepregnancy maternal underweight was 
significantly associated with lower BW and increased risks of LBW and SGA, and 
decreased risks of fetal macrosomia and LGA in singletons who are conceived by ART, 
whereas prepregnancy maternal underweight was not associated with GA and risk of 
PTB. These associations were consistent in the sensitivity analyses and subgroup 
analyses.  
Due to the high prevalence of overweight and obesity in the United States and 
Europe (Flegal et al., 2010; Blundell et al., 2017), a large number of studies have 
focused on the effect of obesity in pregnancies (Maheshwari et al., 2007; Li et al., 
2010). Additionally, studies on the effect of BMI in pregnancies resulting from ART 
have been principally concerned with the number and quality of embryos, conception, 
miscarriage and live birth rates (Bellver et al., 2010; Sermondade et al., 2019). 
Furthermore, the previous studies on the effects of underweight on ART outcomes 
were more focused on the rates of live birth and miscarriage than birth weight (Singh 
et al., 2012; Provost et al., 2016; Wang et al., 2000; Wittemer et al., 2000; Oliveira et 
al., 2018; Cai et al., 2017; Veleva et al., 2008). Therefore, very few studies have 
examined the relationship of underweight mothers with perinatal outcomes in 
singleton infants who are conceived with ART. 
 In our study, we found that singletons who were born to underweight women 
had lower birth weight, higher risks of LBW and SGA and lower risk of fetal 
macrosomia and LGA than those born to women with normal weights after ART 
treatment. Using 180,855 pregnancies with in vitro fertilization (IVF) in the United 
States from 2008 to 2013, Kawwass confirmed that being underweight was associated 
with an increased risk of LBW (RR=1.39, 95% CI=1.25 to 1.54) (Kawwass et al., 
2016). Frankenthal also found that infants of underweight mothers with ART 
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treatment in prepregnancy had higher SGA rates than those born to normal weight 
mothers (31.6% vs 26.6%) (Frankenthal et al., 2019). Those associations were 
similarly existed in spontaneous pregnancies (Tamura et al., 2018; Du et al., 2017; Li 
et al., 2013; Pan et al., 2016; Salihu et al., 2009; Belogolovkin et al., 2009). Han 
preformed a systematic review and meta-analyses that included 78 studies and 
1,025,784 women and reported that in both developed and developing countries, 
underweight women were at an increased risk of having an LBW infant (RR=1.48, 95% 
CI=1.29 to 1.68, and RR=1.52, 95% CI=1.25 to 1.85, respectively) (Han et al., 2011). 
In addition, Rahman reports that maternal underweight was significantly associated 
with a higher risk of LBW (OR=1.66, 95% CI=1.50 to 1.84) and SGA (OR=1.85, 95% 
CI=1.69 to 2.02) in a systematic review and meta-analysis that included 42 studies 
(Rahman et al., 2015). And Liu also found that prepregnancy maternal underweight 
was associated with lower risk of fetal macrosomia (OR=0.55, 95% CI=0.47 to 0.63) 
and LGA (OR=0.52, 95% CI=0.44 to 0.61) in a systematic review and meta-analyses 
(Liu et al., 2016). 
A low prepregnancy BMI may be an indication of chronic nutritional deficiency 
of mothers, including macro- and micronutrients (folate and zinc), which may 
negatively impact the normal processes of fetal growth and development, leading to 
adverse outcomes such as LBW and SGA. A poor maternal nutritional status has been 
associated with a reduction in placental weight and surface area, which may impact 
the ability of nutrients to transfer from the maternal circulation to the developing fetus. 
Based the theory of epigenetics during pregnancy, underweight mothers may not have 
the sufficient nutritional ingredients that are required for the optimal realization of 
epigenetic pathways that drive trophoblastic and fetal growth and development 
(Belogolovkin et al., 2009). 
In our study, prepregnancy maternal underweight was not associated with risk of 
PTB, full term, GA >40 weeks and GA >41 weeks, and the difference in GA was only 
-0.02 week between the underweight and normal weight groups. Han reported that in 
developed countries, underweight women had an increased risk of PTB (RR=1.22, 95% 
CI=1.15 to 1.30) but that this risk was not present in developing countries (RR=0.99, 
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95% CI=0.67 to 1.45) (Han et al., 2011). Han’s results implied that socioeconomic 
status affects the relationship between maternal underweight and PTB. A prospective 
ART cohort study including socioeconomic status was need to identify the 
relationship between maternal underweight and PTB. 
Selection bias and an imbalance of important variables between the groups were 
major problems in previous observational studies (Sturmer et al., 2006), which usually 
used traditional regression methods to analyse the association between maternal 
underweight and perinatal outcomes (Salihu et al., 2009; Kawwass et al., 2016; 
Dickey et al., 2012). For an observational study, PS matching was effective in 
balancing the confounding factors for a similar randomized treatment and reduced the 
selection bias (Austin et al., 2011; D'Agostino et al., 1998) because PS is a function of 
multiple covariates and represents the combined action of multiple covariates. PS 
matching provides an accurate estimated value compared with conventional 
multivariable methods (Cepeda et al., 2003). Thus, the major strength of this study 
was the use of PS matching, which balanced underweight and normal weight groups 
on a large number of covariates by using a linear combination of covariates for a 
single score. To some extent, PS matching also reduced the confounding that may be 
present in our study.  
This study had some limitations. First, this was an observational study in which 
the causality of underweight and pregnancy outcomes could not be established. 
Additionally, although we used the PS matching technique to control for confounders 
between the two groups, the findings in our study might be potentially confounded by 
unmeasured or hidden covariates because the covariates that were used for the PS 
matching were limited, resulting in incomplete or inexact matching. Lastly, because of 
the limitation of hospital information system and follow up system, some 
determinants (gestational weight gain, ethnic group, intrauterine growth retardation, 
preeclampsia, thyroid diseases and glucose intolerance glucose intolerance, chronic 
hypertension, maternal diseases and other pregnancy complications) were not 
adjusted for in the model.  
Conclusion 
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In conclusion, our findings indicate that underweight before ART was 
significantly associated with lower BW, increased risks of LBW and SGA and 
decreased risks of fetal macrosomia and LGA in singletons who are conceived by ART. 
These findings were important for the prevention of adverse birth outcomes in ART 
treatment. An additional large sample multicenter prospective cohort study is needed 
to confirm the risk of prepregnancy maternal underweight. 
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KEY MESSAGE 
Based on a retrospective cohort with 6,538 women undergoing ART and their 
singletons live births and the propensity score (PS) matching analysis, prepregnancy 
maternal underweight was associated with lower birth weight and increased low birth 
weight (LBW) and small for gestational age (SGA) risks in singletons. 
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Table 1 Baseline characteristics of participants by BMI before and after PS matching (n (%)/(mean ± SD)) 
 Before PS match  After PS match 
 
Underweight group 
n=810 
Normal weight group 
n=5728 
P value  
Underweight group 
n=740 
Normal weight group 
n=740 
P value 
Year of transfer        
2006-2009 86 (10.62) 455 (7.94)   79 (10.68) 76 (10.27)  
2010-2012 197 (24.32) 1527 (26.66) 0.022  185 (25.00) 215 (29.05) 0.213 
2013-2015 527 (65.06) 3746 (65.40)   476 (64.32) 449 (60.68)  
Maternal age (year) 28.61 ± 3.63 29.79 ± 4.00 <0.001
a
  28.91 ± 3.56 28.96 ± 3.60 0.783 
Gravidity        
0 537 (66.30) 3290 (57.44)   478 (64.59) 490 (66.22)  
1-2 232 (28.64) 1991 (34.76) <0.001  222 (30.00) 222 (30.00) 0.322 
≥3 41 (5.06) 447 (7.80)   40 (5.41) 28 3.78)  
Parity        
0 770 (95.06) 5224 (91.20) <0.001  700 (94.59) 710 (95.95) 0.221 
≥1 40 (4.94) 504 (8.80)   40 (5.41) 30 (4.05)  
Maternal smoking history 2 (0.25) 18 (0.31) 1.000  2 (0.27) 2 (0.27) 1.000
b
 
Male infertility 328 (40.49) 1994 (34.81) 0.002  287 (38.78) 281 (37.97) 0.748 
Female infertility        
  No 318 (39.26) 1948 (34.01) 
0.001 
 282 (38.11) 274 (37.03) 
0.942 
  Tubal factor 341 (42.10) 2781 (48.55)  325 (43.92) 325 (43.92) 
  PCOS 22 (2.72) 209 (3.65)  21 (2.84) 21 (2.84) 
  Other reasons 129 (15.93) 790 (13.79)  112 (15.14) 120 (16.22) 
Sperm donation 87 (10.74) 391 (6.83) <0.001  55 (7.43) 58 (7.84) 0.769 
Controlled ovarian 458 (56.54) 3353 (58.54) 0.281  428 (57.84) 414 (55.95) 0.462 
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hyperstimulation protocol 
Fertilization method        
  ICSI 238 (30.62) 1551 (27.08)   224 (30.27) 234 (31.62)  
  IVF 549 (67.78) 4042 (70.57) 0.055  504 (68.11) 485 (65.54) 0.219 
  IVF+ICSI 13 (1.60) 135 (2.36)   12 (1.62) 21 (2.84)  
Assisted hatching 224 (27.65) 1580 (27.58) 0.966  204 (27.57) 216 (29.19) 0.489 
Basal serum FSH level (U/L) 7.23 ± 2.12 6.86 ± 2.55 <0.001  7.12 ± 1.98 6.95 ± 2.15 0.105 
Antral follicle count 12.82 ± 4.96 12.86 ± 5.29 0.991
a
  12.89 ± 4.97 12.99 ± 5.35 0.713 
Endometrial thickness (mm) 10.69 ± 2.13 10.74 ± 2.04 0.513  10.71 ± 2.14 10.62 ± 2.05 0.377 
Timing of embryo transfer        
Fresh embryo transfer 460 (56.79) 3359 (58.64) 
0.317 
 428 (57.84) 414 (55.95) 
0.462 
Frozen embryo transfer 350 (43.21) 2369 (41.36)  312 (42.16) 326 (44.05) 
Day 3 or 5        
Cleavage stage transfer 515 (63.58) 3676 (64.18) 
0.741 
 476 (64.32) 479 (64.73) 
0.871 
Blastocyst transfer 295 (63.58) 2052 (35.82)  264 (35.68) 261 (35.27) 
No. of embryos transferred        
1 186 (22.96) 1209 (21.11)   167 (22.57) 149 (20.14)  
  2 567 (70.00) 4105 (71.67) 0.483  516 (69.73) 533 (72.03) 0.520 
  ≥3 57 (7.04) 414 (7.23)   57 (7.70) 58 (7.84)  
No. of gestational sacs by 
ultrasonographic visualization 
       
  1 722 (89.14) 5211 (90.97)   670 (90.54) 665 (89.86)  
  2 85 (10.49) 505 (8.82) 0.134
b
  68 (9.19) 70 (9.46) 0.584
b
 
  ≥3 3 (0.37) 12 (0.21)   2 (0.27) 5 (0.68)  
Infant’s sex=male 421 (51.98) 2980 (52.03) 0.979  389 (52.57) 404 (54.59) 0.434 
a
Wilcoxon rank test; 
b
Fisher exact test.
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Table 2 Effects of underweight on birth outcomes: Results from the GEE model analysis 
Birth outcomes 
No. (%) of 
infants 
Mean ± SD 
Model 1
a
   Model 2
b
  
Difference or relative 
risk (95% CI) 
P value 
Adjusted difference or 
relative risk (95% CI) 
P value 
BW         
BW (g)        
  Normal weight — 3317.24 ± 482.86 Ref   Ref  
  Underweight — 3180.64± 445.43 -136.83 (-184.11 to -89.55) <0.001  -136.83 (-184.11 to -89.55) <0.001 
BW Z scores        
  Normal weight — 0.28 ± 0.99 Ref   Ref  
  Underweight — -0.01 ± 0.89 -0.30 (-0.39 to -0.20) <0.001  -0.30 (-0.39 to -0.20) <0.001 
BW centile        
  Normal weight — 58.15 ± 28.00 Ref   Ref  
  Underweight — 49.73 ± 26.90 -8.41 (-11.21 to -5.62) <0.001  -8.41 (-11.20 to -5.62) <0.001 
BW <2500 g        
  Normal weight 25 (3.92) — Ref   Ref  
  Underweight 41 (5.54) — 1.64 (1.01-2.67) 0.046  1.64 (1.01-2.67) 0.047 
BW=2500-3999 g        
  Normal weight 643 (86.89) — Ref   Ref  
  Underweight 672 (90.81) — 1.04 (1.00-1.08) 0.037  1.04 (1.00-1.08) 0.037 
BW ≥ 4000 g        
  Normal weight 68 (9.19) — Ref   Ref  
  Underweight 27 (3.65) — 0.39 (0.26-0.61) <0.001  0.40 (0.26-0.61) <0.001 
GA        
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GA (week)        
  Normal weight — 39.10 ± 1.42 Ref   Ref  
  Underweight — 39.08 ± 1.59 -0.02 (-0.18 to 0.13) 0.782  -0.02 (-0.17 to 0.13) 0.782 
GA <37 weeks        
  Normal weight 48 (6.49) — Ref   Ref  
  Underweight 49 (6.62) — 1.02 (0.69-1.50) 0.916  1.02 (0.70-1.50) 0.907 
GA=37-42 weeks        
  Normal weight 691 (93.38) — Ref   Ref  
  Underweight 690 (93.24) — 0.99 (0.97-1.03) 0.917  0.99 (0.97-1.03) 0.944 
GA >40 weeks        
  Normal weight 165 (21.35) — Ref   Ref  
  Underweight 158 (22.30) — 0.96 (0.79-1.16) 0.660  0.96 (0.79-1.16) 0.647 
GA >41 weeks        
  Normal weight 28 (3.78) — Ref   Ref  
  Underweight 23 (3.11) — 0.82 (0.48-1.42) 0.477  0.82 (0.48-1.41) 0.473 
SGA, AGA and LGA         
SGA        
  Normal weight 56 (7.57) — Ref   Ref  
  Underweight 82 (11.08) — 1.46 (1.06-2.02) 0.021  1.46 (1.06-2.02) 0.021 
AGA        
  Normal weight 597 (80.68) — Ref   Ref  
  Underweight 627 (84.73) — 1.05 (1.00-1.10) 0.040  1.05 (1.01-1.10) 0.040 
LGA        
  Normal weight 87 (11.76) — Ref   Ref  
  Underweight 31 (4.19) — 0.36 (0.24-0.53) <0.001  0.36 (0.24-0.53) <0.001 
a 
Model 1 included only the study variable. 
b
 Model 2 adjusted for all of the baseline covariates.  
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Table 3 Effects of underweight on BW, GA and SGA: Results from the generalized linear model analysis in subgroups before PS matching 
 
Subgroup N 
Adjusted difference or 
relative risk (95% CI) 
P value P for interaction 
BW (g)      
Maternal age (year) Tertile 1 (20-27) 2104 -134.46 (-191.23 to -77.68) <0.001 0.423 
 Tertile 2 (28-30) 1974 -125.30 (-191.23 to -59.36) <0.001 
 Tertile 3 (>30) 2460 -74.19 (-144.46 to -3.92) 0.039 
Gravidity 0  3827 -110.60 (-155.29 to -65.92) <0.001 0.890 
 ≥ 1  2711 -113.72 (-178.25 to -49.18) <0.001 
Fertilization method ICSI 1799 -147.50 (-213.02 to -81.97) <0.001 0.240 
 IVF 4591 -96.10 (-141.40 to -50.79) <0.001 
FSH (U/L) Tertile 1 (<5.97) 2182 -139.09 (-214.41 to -63.78) <0.001 0.643 
 Tertile 2 (5.98-7.40) 2177 -111.90 (-175.05 to -48.74) <0.001 
 Tertile 3 (>7.40) 2179 -90.73 (-148.16 to -33.34) 0.002 
Timing of embryo transfer Fresh embryo transfer 3819 -130.84 (-176.36 to -82.32) <0.001 0.402 
 Frozen embryo transfer 2719 -92.67 (-152.69 to -32.64) 0.003 
Day 3 or 5 Cleavage stage transfer 4191 -130.89 (-176.41 to -85.37) <0.001 0.193 
 Blastocyst transfer 2347 -82.07 (-145.51 to -18.63) 0.011 
Endometrial thickness (mm) Tertile 1 (<9.6) 2217 -111.99 (-176.56 to -47.42) <0.001 0.644 
 Tertile 2 (9.7-11.4) 2164 -88.27 (-152.51 to -24.03) 0.007 
 Tertile 3 (>11.4) 2157 -133.17 (-196.79 to -69.55) <0.001 
No. of embryos transferred 1  1395 -92.57 (-169.40 to -15.77) 0.018 0.619 
 ≥ 2  5143 -116.13 (-158.35 to -73.92) <0.001 
Infant’s sex Boy 3401 -135.08 (-187.66 to -82.83) <0.001 0.258 
 Girl 3137 -87.85 (-139.76 to -35.93) <0.001 
GA (week)      
Maternal age (year) Tertile 1 (20-27) 2104 -0.10 (-0.28 to 0.07) 0.237 0.141 
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 Tertile 2 (28-30) 1974 1.17 (-0.07 to 0.41) 0.159 
 Tertile 3 (>30) 2460 -0.06 (-0.29 to 0.16) 0.587 
Gravidity 0  3827 0.01 (-0.13 to 0.16) 0.847 0.852 
 ≥ 1  2711 0.00 (-0.21 to 0.21) 0.999 
Fertilization method ICSI 1799 0.01 (-0.20 to 0.21) 0.958 0.106 
 IVF 4591 0.03 (-0.12 to 0.18) 0.736 
FSH (U/L) Tertile 1 (<5.97) 2182 -0.01 (-0.26 to 0.23) 0.915 0.890 
 Tertile 2 (5.98-7.40) 2177 -0.01 (-0.22 to 0.19) 0.906 
 Tertile 3 (>7.40) 2179 0.04 (-0.16 to 0.24) 0.696 
Timing of embryo transfer Fresh embryo transfer 3819 -0.07 (-0.22 to 0.09) 0.397 0.038 
 Frozen embryo transfer 2719 0.15 (-0.05 to 0.36) 0.132 
Day 3 or 5 Cleavage stage transfer 4191 -0.06 (-0.21 to 0.09) 0.399 0.200 
 Blastocyst transfer 2347 0.10 (-0.11 to 0.31) 0.341 
Endometrial thickness (mm) Tertile 1 (<9.6) 2217 -0.07 (-0.28 to 0.14) 0.504 0.588 
 Tertile 2 (9.7-11.4) 2164 0.05 (-0.15 to 0.26) 0.611 
 Tertile 3 (>11.4) 2157 0.01 (-0.20 to 0.22) 0.920 
No. of embryos transferred 1  1395 -0.03 (-0.28 to 0.21) 0.780 0.712 
 ≥ 2  5143 0.01 (-0.13 to 0.15) 0.885 
Infant’s sex Boy 3401 -0.02 (-0.19 to 0.15) 0.846 0.852 
 Girl 3137 0.01 (-0.16 to 0.19) 0.883 
SGA      
Maternal age (year) Tertile 1(20-27) 2104 1.36 (0.95-1.94) 0.093 0.186 
 Tertile 2 (28-30) 1974 1.78 (1.25-2.55) 0.002 
 Tertile 3 (>30) 2460 1.08 (0.70-1.66) 0.734 
Gravidity 0  3827 1.49 (1.16-1.93) 0.002 0.279 
 ≥ 1  2711 1.17 (0.77-1.77) 0.471 
Fertilization method ICSI 1799 1.65 (1.13-2.41) 0.010 0.463 
 IVF 4591 1.27 (0.97-1.66) 0.086 
FSH (U/L) Tertile 1 (<5.97) 2182 1.57 (1.02-2.45) 0.041 0.875 
 Tertile 2 (5.98-7.40) 2177 1.45 (1.02-2.05) 0.038 
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 Tertile 3 (>7.40) 2179 1.29 (0.91-1.84) 0.157 
Timing of embryo transfer Fresh embryo transfer 3819 1.42 (1.10-1.84) 0.007 0.780 
 Frozen embryo transfer 2719 1.34 (0.89-2.02) 0.158 
Day 3 or 5 Cleavage stage transfer 4191 1.36 (1.04-1.78) 0.027 0.851 
 Blastocyst transfer 2347 1.46 (1.02-2.09) 0.040 
Endometrial thickness (mm) Tertile 1 (<9.6) 2217 1.52 (1.04-2.21) 0.029 0.581 
 Tertile 2 (9.7-11.4) 2164 1.15 (0.77-1.71) 0.494 
 Tertile 3 (>11.4) 2157 1.51 (1.06-2.16) 0.022 
No. of embryos transferred 1  1395 1.29 (0.83-2.00) 0.257 0.692 
 ≥ 2  5143 1.42 (1.11-1.83) 0.005 
Infant’s sex Boy 3401 1.39 (1.03-1.88) 0.031 0.768 
 Girl 3137 1.41 (1.03-1.92) 0.031 
Maternal age, FSH, and endometrial thickness were classified by tertiles. All of the baseline covariates were adjusted in the Model. Peak estradiol 
level was also adjusted in the Model in fresh embryo transfer group. 
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Figure 1. Flow diagram of sampling strategy with exclusion criteria. 
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Figure 2. Absolute standardized differences before and after PS matching. 
 
